We are live on
!
Find out more
TCM
Tanaka Capital Management Portfolio holdings
AUM
$59.9M
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$39.5M
AUM Growth
-$797K
(-2%)
Cap. Flow
+$3.29M
Cap. Flow
% of AUM
8.32%
Top 10 Holdings %
Top 10 Hldgs %
67.01%
Holding
62
New
2
Increased
12
Reduced
4
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Opko Health
OPK
|
+$1.66M |
| 2 |
CELG
Celgene Corp
CELG
|
+$819K |
| 3 |
Bausch Health
BHC
|
+$548K |
| 4 |
Helen of Troy
HELE
|
+$340K |
| 5 |
Oshkosh
OSK
|
+$145K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synaptics
SYNA
|
+$2.47M |
| 2 |
BRLI
BIO-REFERENCE LABS INC-NEW-
BRLI
|
+$1.93M |
| 3 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
+$945K |
| 4 |
Yum! Brands
YUM
|
+$715K |
| 5 |
Alaska Air
ALK
|
+$17.9K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.95% |
| 2 | Technology | 23.95% |
| 3 | Industrials | 12.74% |
| 4 | Consumer Staples | 3.95% |
| 5 | Financials | 3.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Zimmer Biomet
ZBH
$18.2B
| $5K | 0.01% |
57
| – | – |
|
52
Teradyne
TER
$57.6B
| $4K | 0.01% |
235
| – | – |
|
53
Veeco
VECO
$3.05B
| $4K | 0.01% |
198
| – | – |
|
54
Travelers Companies
TRV
$78.1B
| $1K | ﹤0.01% |
6
| – | – |
|
|
55
Yum! Brands
YUM
$41.8B
| – | – |
-11,038
| Closed | -$715K |
|
|
MNK
56
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – |
-8,030
| Closed | -$945K |
|
|
BRLI
57
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
| – | – |
-46,830
| Closed | -$1.93M |
|
Similar funds
GC
GCS
NI
CMANY
GMC
JCM
PCA
ACM
Tanaka Capital Management's Q3 2015 Portfolio in Review
As of Q3 2015, Tanaka Capital Management held 62 positions worth $39.5M, down 2% from $40.3M the previous quarter. Its ten largest holdings account for 67% of the portfolio.
Tanaka Capital Management deployed $3.29M of net new capital in Q3 2015, opening 2 new positions and adding to 12 existing holdings. Its largest new stake was Opko Health: 125,184 shares worth $1.05M.
By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Technology and Industrials.
On the sell side, the largest reduction was Synaptics, an estimated $2.47M trimmed.
- Tanaka Capital Management's largest Q3 2015 buy was Opko Health: 125,184 shares worth $1.05M.
- Tanaka Capital Management added most to Celgene Corp in Q3 2015, an estimated $819K increase.
- Tanaka Capital Management's biggest Q3 2015 reduction was Synaptics, cutting an estimated $2.47M.
- Tanaka Capital Management fully exited BIO-REFERENCE LABS INC-NEW- in Q3 2015, selling an estimated $1.93M.
- Tanaka Capital Management's ten largest holdings make up 67% of its $39.5M portfolio in Q3 2015.
- Tanaka Capital Management opened 2 new positions and closed 3 in Q3 2015.
- Tanaka Capital Management's portfolio value fell 2% quarter-over-quarter to $39.5M.
Based on Tanaka Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.